According to Latest Study , the global market for Orally Administered Vaccine should grow from US$ 2540 million in 2023 to US$ 3746.5 million by 2030, with a CAGR of 5.7% for the period of 2024-2030.

China Orally Administered Vaccine market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Orally Administered Vaccine market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Rotavirus Vaccine segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Public has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Orally Administered Vaccine include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. 

This report aims to provide a comprehensive study of the global market for Orally Administered Vaccine. Report Highlights:

(1) Global Orally Administered Vaccine market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Orally Administered Vaccine market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Orally Administered Vaccine market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Orally Administered Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Orally Administered Vaccine segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Orally Administered Vaccine, capacity, production and trends.

(7) Orally Administered Vaccine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Other

Market segment by application, can be divided into

Public

Private

Market segment by players, this report covers

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

1 Market Overview

1.1 Orally Administered Vaccine Definition

1.2 Global Orally Administered Vaccine Market Size and Forecast

1.2.1 By Revenue, Global Orally Administered Vaccine Market Size, 2019-2030

1.2.2 By Sales Volume, Global Orally Administered Vaccine Market Size, 2019-2030

1.2.3 Global Orally Administered Vaccine Price Trend, 2019-2030

1.3 China Orally Administered Vaccine Market Size and Forecast

1.3.1 By Revenue, China Orally Administered Vaccine Market Size, 2019-2030

1.3.2 By Sales Volume, China Orally Administered Vaccine Market Size, 2019-2030

1.3.3 China Orally Administered Vaccine Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Orally Administered Vaccine Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Orally Administered Vaccine Share in Global Market, 2019-2030

1.4.3 Orally Administered Vaccine Market Size: China VS Global, 2019-2030

1.5 Orally Administered Vaccine Market Dynamics

1.5.1 Orally Administered Vaccine Market Drivers

1.5.2 Orally Administered Vaccine Market Restraints

1.5.3 Orally Administered Vaccine Industry Trends

1.5.4 Orally Administered Vaccine Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Orally Administered Vaccine Revenue by Company, 2019-2024

2.2 Global Orally Administered Vaccine Sales Volume by Company, 2019-2024

2.3 Global Orally Administered Vaccine Price by Company, 2019-2024

2.4 Global Orally Administered Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Orally Administered Vaccine Concentration Ratio

2.6 Global Orally Administered Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Orally Administered Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Orally Administered Vaccine Revenue by Company, 2019-2024

3.2 China Orally Administered Vaccine Sales Volume by Company, 2019-2024

3.3 China Orally Administered Vaccine Orally Administered Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Orally Administered Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Orally Administered Vaccine Domestic VS Export

3.6 China Market, Orally Administered Vaccine Import & Export

3.6.1 China Market, Orally Administered Vaccine Import & Export, 2019-2030

3.6.2 China Orally Administered Vaccine Import & Export Trends

3.6.3 Main Sources of China Orally Administered Vaccine Import

3.6.4 Export Destination of China Orally Administered Vaccine

4 Orally Administered Vaccine Production by Region

4.1 Global Orally Administered Vaccine Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Orally Administered Vaccine Manufacturers

4.3 Global Major Manufacturers, Orally Administered Vaccine Capacity Expansion and Future Plans

4.4 Global Orally Administered Vaccine Capacity by Region

4.5 Global Orally Administered Vaccine Production by Region

4.5.1 Global Orally Administered Vaccine Production & Forecast by Region, 2019 VS 2023 VS 2030

4.5.2 Global Orally Administered Vaccine Production by Region, 2019-2024

4.5.3 Global Orally Administered Vaccine Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Orally Administered Vaccine Industry Chain

5.2 Orally Administered Vaccine Upstream Analysis

5.2.1 Orally Administered Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Orally Administered Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Orally Administered Vaccine Production Mode

5.6 Orally Administered Vaccine Procurement Model

5.7 Orally Administered Vaccine Industry Sales Model and Sales Channels

5.7.1 Orally Administered Vaccine Sales Model

5.7.2 Orally Administered Vaccine Typical Distributors

6 Sights by Type

6.1 Orally Administered Vaccine Classification

6.1.1 Rotavirus Vaccine

6.1.2 Cholera Vaccine

6.1.3 Oral Polio Vaccine

6.1.4 Other

6.2 By Type, Global Orally Administered Vaccine Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Type, Global Orally Administered Vaccine Revenue, 2019-2030

6.4 By Type, Global Orally Administered Vaccine Sales Volume, 2019-2030

6.5 By Type, Global Orally Administered Vaccine Price, 2019-2030

7 Sights by Application

7.1 Orally Administered Vaccine Segment by Application

7.1.1 Public

7.1.2 Private

7.2 By Application, Global Orally Administered Vaccine Market Size & CAGR, 2019 VS 2023 VS 2030

7.3 By Application, Global Orally Administered Vaccine Revenue, 2019-2030

7.4 By Application, Global Orally Administered Vaccine Sales Volume, 2019-2030

7.5 By Application, Global Orally Administered Vaccine Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Orally Administered Vaccine Market Size, 2019 VS 2023 VS 2030

8.2 By Region, Global Orally Administered Vaccine Revenue, 2019-2030

8.3 By Region, Global Orally Administered Vaccine Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Orally Administered Vaccine Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Orally Administered Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Orally Administered Vaccine Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Orally Administered Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Orally Administered Vaccine Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Orally Administered Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Orally Administered Vaccine Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Orally Administered Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Orally Administered Vaccine Market Size & CAGR，2019 VS 2023 VS 2030

9.2 By Country, Global Orally Administered Vaccine Revenue, 2019-2030

9.3 By Country, Global Orally Administered Vaccine Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Orally Administered Vaccine Market Size, 2019-2030

9.4.2 By Company, U.S. Orally Administered Vaccine Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Orally Administered Vaccine Market Size, 2019-2030

9.5.2 By Company, Europe Orally Administered Vaccine Sales Volume Market Share, 2022

9.5.3 By Type, Europe Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Orally Administered Vaccine Market Size, 2019-2030

9.6.2 By Company, China Orally Administered Vaccine Sales Volume Market Share, 2022

9.6.3 By Type, China Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Orally Administered Vaccine Market Size, 2019-2030

9.7.2 By Company, Japan Orally Administered Vaccine Sales Volume Market Share, 2022

9.7.3 By Type, Japan Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Orally Administered Vaccine Market Size, 2019-2030

9.8.2 By Company, South Korea Orally Administered Vaccine Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Orally Administered Vaccine Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Orally Administered Vaccine Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Orally Administered Vaccine Market Size, 2019-2030

9.10.2 By Company, India Orally Administered Vaccine Sales Volume Market Share, 2022

9.10.3 By Type, India Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Orally Administered Vaccine Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Orally Administered Vaccine Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Orally Administered Vaccine Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Orally Administered Vaccine Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 Merck

10.1.1 Merck Company Information, Head Office, Market Area and Industry Position

10.1.2 Merck Orally Administered Vaccine Models, Specifications and Application

10.1.3 Merck Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Merck Company Profile and Main Business

10.1.5 Merck Recent Developments

10.2 GSK

10.2.1 GSK Company Information, Head Office, Market Area and Industry Position

10.2.2 GSK Orally Administered Vaccine Models, Specifications and Application

10.2.3 GSK Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 GSK Company Profile and Main Business

10.2.5 GSK Recent Developments

10.3 Sanofi

10.3.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.3.2 Sanofi Orally Administered Vaccine Models, Specifications and Application

10.3.3 Sanofi Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Sanofi Company Profile and Main Business

10.3.5 Sanofi Recent Developments

10.4 Lanzhou Institute

10.4.1 Lanzhou Institute Company Information, Head Office, Market Area and Industry Position

10.4.2 Lanzhou Institute Orally Administered Vaccine Models, Specifications and Application

10.4.3 Lanzhou Institute Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Lanzhou Institute Company Profile and Main Business

10.4.5 Lanzhou Institute Recent Developments

10.5 Serum Institute

10.5.1 Serum Institute Company Information, Head Office, Market Area and Industry Position

10.5.2 Serum Institute Orally Administered Vaccine Models, Specifications and Application

10.5.3 Serum Institute Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Serum Institute Company Profile and Main Business

10.5.5 Serum Institute Recent Developments

10.6 Valneva

10.6.1 Valneva Company Information, Head Office, Market Area and Industry Position

10.6.2 Valneva Orally Administered Vaccine Models, Specifications and Application

10.6.3 Valneva Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Valneva Company Profile and Main Business

10.6.5 Valneva Recent Developments

10.7 Shanghai United Cell

10.7.1 Shanghai United Cell Company Information, Head Office, Market Area and Industry Position

10.7.2 Shanghai United Cell Orally Administered Vaccine Models, Specifications and Application

10.7.3 Shanghai United Cell Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Shanghai United Cell Company Profile and Main Business

10.7.5 Shanghai United Cell Recent Developments

10.8 Bibcol

10.8.1 Bibcol Company Information, Head Office, Market Area and Industry Position

10.8.2 Bibcol Orally Administered Vaccine Models, Specifications and Application

10.8.3 Bibcol Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Bibcol Company Profile and Main Business

10.8.5 Bibcol Recent Developments

10.9 PaxVax

10.9.1 PaxVax Company Information, Head Office, Market Area and Industry Position

10.9.2 PaxVax Orally Administered Vaccine Models, Specifications and Application

10.9.3 PaxVax Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 PaxVax Company Profile and Main Business

10.9.5 PaxVax Recent Developments

10.10 Vabiotech

10.10.1 Vabiotech Company Information, Head Office, Market Area and Industry Position

10.10.2 Vabiotech Orally Administered Vaccine Models, Specifications and Application

10.10.3 Vabiotech Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Vabiotech Company Profile and Main Business

10.10.5 Vabiotech Recent Developments

10.11 Tiantan Biological

10.11.1 Tiantan Biological Company Information, Head Office, Market Area and Industry Position

10.11.2 Tiantan Biological Orally Administered Vaccine Models, Specifications and Application

10.11.3 Tiantan Biological Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Tiantan Biological Company Profile and Main Business

10.11.5 Tiantan Biological Recent Developments

10.12 EuBiologics

10.12.1 EuBiologics Company Information, Head Office, Market Area and Industry Position

10.12.2 EuBiologics Orally Administered Vaccine Models, Specifications and Application

10.12.3 EuBiologics Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.12.4 EuBiologics Company Profile and Main Business

10.12.5 EuBiologics Recent Developments

10.13 Panacea Biotec Ltd

10.13.1 Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

10.13.2 Panacea Biotec Ltd Orally Administered Vaccine Models, Specifications and Application

10.13.3 Panacea Biotec Ltd Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Panacea Biotec Ltd Company Profile and Main Business

10.13.5 Panacea Biotec Ltd Recent Developments

10.14 Bio-Med

10.14.1 Bio-Med Company Information, Head Office, Market Area and Industry Position

10.14.2 Bio-Med Orally Administered Vaccine Models, Specifications and Application

10.14.3 Bio-Med Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.14.4 Bio-Med Company Profile and Main Business

10.14.5 Bio-Med Recent Developments

10.15 Halfkin Bio-Pharmaceuticals

10.15.1 Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Models, Specifications and Application

10.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.15.4 Halfkin Bio-Pharmaceuticals Company Profile and Main Business

10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Orally Administered Vaccine Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Orally Administered Vaccine Market Restraints

Table 3. Orally Administered Vaccine Market Trends

Table 4. Orally Administered Vaccine Industry Policy

Table 5. Global Orally Administered Vaccine Revenue by Company, 2019-2024, US$ million

Table 6. Global Orally Administered Vaccine Revenue Market Share by Company, 2019-2024

Table 7. Global Orally Administered Vaccine Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Orally Administered Vaccine Sales Volume Market Share by Company, 2019-2024

Table 9. Global Orally Administered Vaccine Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Orally Administered Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Orally Administered Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Orally Administered Vaccine Manufacturers Product Type

Table 13. China Orally Administered Vaccine Revenue by Company, 2019-2024, US$ million

Table 14. China Orally Administered Vaccine Revenue Market Share by Company, 2019-2024

Table 15. China Orally Administered Vaccine Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Orally Administered Vaccine Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Orally Administered Vaccine Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Orally Administered Vaccine Import & Export Trends

Table 19. Main Sources of China Orally Administered Vaccine Import

Table 20. Export Destination of China Orally Administered Vaccine

Table 21. Global Headquarters and Manufacturing Base of Orally Administered Vaccine Manufacturers

Table 22. Global Major Manufacturers, Orally Administered Vaccine Capacity Expansion and Future Plans

Table 23. Global Orally Administered Vaccine Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Orally Administered Vaccine Production by Region, 2019-2024, (K Units)

Table 25. Global Orally Administered Vaccine Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Orally Administered Vaccine Upstream (Raw Materials)

Table 27. Global Orally Administered Vaccine Typical Customers

Table 28. Orally Administered Vaccine Typical Distributors

Table 29. By Type, Global Orally Administered Vaccine Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Orally Administered Vaccine Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Orally Administered Vaccine Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Orally Administered Vaccine Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Table 37. By Country, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Table 39. Merck Company Information, Head Office, Market Area and Industry Position

Table 40. Merck Orally Administered Vaccine Models, Specifications and Application

Table 41. Merck Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Merck Company Profile and Main Business

Table 43. Merck Recent Developments

Table 44. GSK Company Information, Head Office, Market Area and Industry Position

Table 45. GSK Orally Administered Vaccine Models, Specifications and Application

Table 46. GSK Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. GSK Company Profile and Main Business

Table 48. GSK Recent Developments

Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 50. Sanofi Orally Administered Vaccine Models, Specifications and Application

Table 51. Sanofi Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Sanofi Company Profile and Main Business

Table 53. Sanofi Recent Developments

Table 54. Lanzhou Institute Company Information, Head Office, Market Area and Industry Position

Table 55. Lanzhou Institute Orally Administered Vaccine Models, Specifications and Application

Table 56. Lanzhou Institute Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Lanzhou Institute Company Profile and Main Business

Table 58. Lanzhou Institute Recent Developments

Table 59. Serum Institute Company Information, Head Office, Market Area and Industry Position

Table 60. Serum Institute Orally Administered Vaccine Models, Specifications and Application

Table 61. Serum Institute Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Serum Institute Company Profile and Main Business

Table 63. Serum Institute Recent Developments

Table 64. Valneva Company Information, Head Office, Market Area and Industry Position

Table 65. Valneva Orally Administered Vaccine Models, Specifications and Application

Table 66. Valneva Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Valneva Company Profile and Main Business

Table 68. Valneva Recent Developments

Table 69. Shanghai United Cell Company Information, Head Office, Market Area and Industry Position

Table 70. Shanghai United Cell Orally Administered Vaccine Models, Specifications and Application

Table 71. Shanghai United Cell Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Shanghai United Cell Company Profile and Main Business

Table 73. Shanghai United Cell Recent Developments

Table 74. Bibcol Company Information, Head Office, Market Area and Industry Position

Table 75. Bibcol Orally Administered Vaccine Models, Specifications and Application

Table 76. Bibcol Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Bibcol Company Profile and Main Business

Table 78. Bibcol Recent Developments

Table 79. PaxVax Company Information, Head Office, Market Area and Industry Position

Table 80. PaxVax Orally Administered Vaccine Models, Specifications and Application

Table 81. PaxVax Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. PaxVax Company Profile and Main Business

Table 83. PaxVax Recent Developments

Table 84. Vabiotech Company Information, Head Office, Market Area and Industry Position

Table 85. Vabiotech Orally Administered Vaccine Models, Specifications and Application

Table 86. Vabiotech Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Vabiotech Company Profile and Main Business

Table 88. Vabiotech Recent Developments

Table 89. Tiantan Biological Company Information, Head Office, Market Area and Industry Position

Table 90. Tiantan Biological Orally Administered Vaccine Models, Specifications and Application

Table 91. Tiantan Biological Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Tiantan Biological Company Profile and Main Business

Table 93. Tiantan Biological Recent Developments

Table 94. EuBiologics Company Information, Head Office, Market Area and Industry Position

Table 95. EuBiologics Orally Administered Vaccine Models, Specifications and Application

Table 96. EuBiologics Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. EuBiologics Company Profile and Main Business

Table 98. EuBiologics Recent Developments

Table 99. Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

Table 100. Panacea Biotec Ltd Orally Administered Vaccine Models, Specifications and Application

Table 101. Panacea Biotec Ltd Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Panacea Biotec Ltd Company Profile and Main Business

Table 103. Panacea Biotec Ltd Recent Developments

Table 104. Bio-Med Company Information, Head Office, Market Area and Industry Position

Table 105. Bio-Med Orally Administered Vaccine Models, Specifications and Application

Table 106. Bio-Med Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Bio-Med Company Profile and Main Business

Table 108. Bio-Med Recent Developments

Table 109. Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 110. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Models, Specifications and Application

Table 111. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Halfkin Bio-Pharmaceuticals Company Profile and Main Business

Table 113. Halfkin Bio-Pharmaceuticals Recent Developments

List of Figure

Figure 1. Orally Administered Vaccine Picture

Figure 2. By Revenue, Global Orally Administered Vaccine Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Orally Administered Vaccine Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Orally Administered Vaccine Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Orally Administered Vaccine Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Orally Administered Vaccine Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Orally Administered Vaccine Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Orally Administered Vaccine Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Orally Administered Vaccine Share of Global Market, 2019-2030

Figure 10. Global Orally Administered Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Orally Administered Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Orally Administered Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Orally Administered Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Orally Administered Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Orally Administered Vaccine Domestic VS Export, 2022

Figure 16. Global Orally Administered Vaccine Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Orally Administered Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Orally Administered Vaccine Production Market Share & Forecast by Region, 2019-2030

Figure 19. Orally Administered Vaccine Industry Chain

Figure 20. Orally Administered Vaccine Procurement Model

Figure 21. Orally Administered Vaccine Sales Model

Figure 22. Orally Administered Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. Rotavirus Vaccine

Figure 24. Cholera Vaccine

Figure 25. Oral Polio Vaccine

Figure 26. Other

Figure 27. By Type, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Figure 28. By Type, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Figure 29. By Type, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 30. By Type, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Figure 31. By Type, Global Orally Administered Vaccine Price, 2019-2030, (US$/Unit)

Figure 32. Public

Figure 33. Private

Figure 34. By Application, Global Orally Administered Vaccine Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Figure 36. By Application, Global Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global Orally Administered Vaccine Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global Orally Administered Vaccine Revenue Market Share, 2019-2030

Figure 40. By Region, Global Orally Administered Vaccine Sales Volume Market Share, 2019-2030

Figure 41. North America Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America Orally Administered Vaccine Revenue Market Share, 2022

Figure 43. Europe Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe Orally Administered Vaccine Revenue Market Share, 2022

Figure 45. Asia Pacific Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific Orally Administered Vaccine Revenue Market Share, 2022

Figure 47. South America Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America Orally Administered Vaccine Revenue Market Share, 2022

Figure 49. Middle East & Africa Orally Administered Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. Orally Administered Vaccine Market Share, 2022

Figure 52. By Type, U.S. Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe Orally Administered Vaccine Market Share, 2022

Figure 56. By Type, Europe Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 58. China Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China Orally Administered Vaccine Market Share, 2022

Figure 60. By Type, China Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan Orally Administered Vaccine Market Share, 2022

Figure 64. By Type, Japan Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea Orally Administered Vaccine Market Share, 2022

Figure 68. By Type, South Korea Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia Orally Administered Vaccine Market Share, 2022

Figure 72. By Type, Southeast Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 74. India Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India Orally Administered Vaccine Market Share, 2022

Figure 76. By Type, India Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Orally Administered Vaccine Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia Orally Administered Vaccine Market Share, 2022

Figure 80. By Type, Middle East & Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Orally Administered Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)